8th Annual MIBio Conference
MIBio 2018: Stability of Biopharmaceuticals – From molecular interactions to successful products
The MIBio conference series engages world leading experts from industry and academia in a discussion in how the latest molecular interaction based discoveries can be exploited in biopharmaceutical formulation to produce more effective, patient-friendly and safer therapeutic products.
With growing competition in the market, patient-centric product strategies, an increasing variety of products in development and more complex regulatory requirements, the demand for formulation of therapeutic proteins are increasing. In addition, the formulation patent landscape is becoming more complicated which further contributes to the challenge of development robust dosage forms. MIBio 2018 will focus on discussing these challenges as well as strategies to overcome them, particularly focusing on formulation, drug product development and device and regulatory strategies.
We expect more than 100 delegates from industry and academia to create an interesting and stimulating event fostering new collaborations and discoveries that will help steer the development of the next generation formulation technologies. We will be inviting abstracts for poster submissions and welcome applications for sponsor and exhibitor slots on the day.
MIBio 2018 is organised by the Formulation Science and Technology Group (FSTG) and the Joint Colloids Group (SCI) of the Royal Society of Chemistry (RSC) together with the Academy of Pharmaceutical Sciences (APS). The event will be held on 15th November 2018, Howard Theatre, Downing College, Cambridge, UK.
We look forward to seeing you at MIBio 2018!
For further details please visit the Formulation Science and Technology Group website FSTG MIBIO 2018 WEBSITE
The MIBio organising committee is:
Jan Jezek | Arecor
Nicholas J. Darton | Arecor
Tejash Shah | GSK
Stephen Harding | University of Nottingham
Bernardo Perez-Ramirez | Sanofi